Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to reduce appetite, improve insulin secretion, and increase energy expenditure
9,650 adults, age 50 years or older Type 2 diabetes and at least one of the following: coronary artery disease, stroke, symptomatic peripheral artery disease, or reduced kidney function Hemoglobin A1c between 6.5 and 10.0 percent Randomized to receive oral semaglutide (up to 14 milligrams per day) or placebo, in addition to usual care Median follow-up of 49.5 months What did they find
Once shipped, you'll receive a tracking number via email to monitor your delivery in real time
Combining peptides with our other wellness services To help you achieve the best possible results, we often recommend combining peptide therapy with our other wellness services
Medical supervision helps with: Candidate evaluation Medication selection Dosing decisions Side effect monitoring Lab review Nutrition guidance Muscle preservation Treatment adjustments Long-term maintenance planning At SOTA Wellness, medication is only one part of the plan
L., & Pratley, R
